University TMS Clinic Now Offering FDA-Cleared Helmet to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disor...
July 21 2020 - 9:00AM
University TMS, a mental health facility specializing in advanced
treatments for neurological and psychiatric disorders, is now
offering BrainsWay’s Deep Transcranial Magnetic Stimulation (Deep
TMS) for major depressive disorder (MDD) and obsessive-compulsive
disorder (OCD).
“We have learned that each year more than 20% of
the Alabama population meets the requirements for a mental health
diagnosis,” said Dr. Timothy Prestley, M.D., founder and
neurologist at University TMS. “Our mission is to provide hope
through innovative and noninvasive treatment options, such as Deep
TMS. Many mental illnesses, including depression and OCD, have been
exacerbated during the COVID-19 pandemic, and we want to have every
tool in our belt to help those living in the Tuscaloosa County
community.”
BrainsWay’s Deep TMS administers magnetic waves
through a cushioned helmet to target deep structures of the brain
that impact a patients’ depression and OCD symptoms. The treatment
is both noninvasive and medication-free, and patients can return to
normal activities, such as driving, immediately following the
session. Because Deep TMS penetrates deeper and broader in the
brain than traditional TMS, it enables stimulation of the deep
brain structures that are involved in mental health illnesses.
BrainsWay has been treating depression with Deep TMS for more than
10 years and received FDA clearance to target OCD in 2018.
University TMS was founded by Dr. Prestley and
Dr. James T. O’Neil, M.D. who have more than 10 years of combined
experience in the diagnosis and treatment of all aspects of
neurological disorders both in the hospital and outpatient setting.
For more information, visit www.universitytmstherapy.com or call
the clinic at 205-523-5618.
About University TMS Located in Tuscaloosa,
University TMS provides comprehensive treatments to effectively
treat depression, addiction, and other brain disorders with
non-surgical treatments, such as Deep TMS.
About BrainsWayBrainsWay Ltd./ BrainsWay USA
(NASDAQ: BWAY), is engaged in the research, development and sales
and marketing of a medical system for noninvasive treatment of
common brain disorders. The medical system developed and
manufactured by the Company is based on a unique breakthrough
technology called Deep TMS, which can reach significant depth and
breadth of the brain and produce broad stimulation and functional
modulation of targeted brain areas. In the U.S., the Company’s
device has been FDA cleared for the treatment of major depressive
disorder (MDD) since 2013 and is now FDA cleared (De-Novo) for the
treatment of obsessive-compulsive disorder (OCD). The Company’s
systems have also received CE clearance and are sold worldwide for
the treatment of various brain disorders.
BrainsWay Media Contact:Holly
DuganBrainsway@antennagroup.com(201) 465-8019
Brainsway (NASDAQ:BWAY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Brainsway (NASDAQ:BWAY)
Historical Stock Chart
From Sep 2023 to Sep 2024